A practical reference on LKKTETQ: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
| Property | Value | Notes |
|---|---|---|
| Analytical method | LC-MS/MS | Preferred confirmatory technique |
| Appearance | White to off-white powder | Lyophilised form |
| Solubility | Freely soluble in water | Also described in saline |
| Storage temperature | Below -20 °C for powder | Short-term refrigeration for solutions |
| Regulatory status | Prohibited in sport | Listed under peptide hormones |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
=== Deliberate === Although 210Po occurs in trace amounts in nature, it is not abundant enough (0.1 ppb) for extraction from uranium ore to be feasible. Instead, most 210Po is produced synthetically, through neutron bombardment of 209Bi in a nuclear reactor. This process converts 209Bi to 210Bi, which has a half-life of five days and beta decays to 210Po. Through this method, it was reported in February 2007 that approximately 8 grams (0.28 oz) of 210Po was produced in Russia and shipped to the United States every month for commercial applications.
=== Online === Peters, known to his online followers as "Clav", became popular online by 2025 for his content focused on looksmaxxing on both Kick and TikTok. His alias "Clavicular" is based on the emphasis placed on clavicle width within the looksmaxxing community. He instructs fans on how to "ascend", or to become more attractive and ostensibly gain social power and sexual prospects as a result, and to "hardmaxx", a looksmaxxing term for undergoing intense and painful physical alterations. Peters' looksmaxxing content includes traditional bodybuilding and fitness training, along with "a new focus on sort of facial esthetics". He has participated in and advocated for looksmaxxing practices such as "bonesmashing", a pseudoscientific practice involving hitting one's facial bones with a hammer or fist in order to create microscopic bone fractures with the hope that one's jaw would heal in a more pleasing shape. Peters has also acknowledged taking methamphetamine to suppress his appetite and remain thin. He has spoken about taking anabolic steroids over several years to become more muscular, which, according to him, made him infertile by 2025 due to his body no longer naturally producing testosterone. By late 2025, he also began selling access to a self-improvement and looksmaxxing course called the "Clavicular System", later called "Clavicular's Clan", for $50 per month. The course provides guides on how to "ascend" and on suggested peptides to inject in order to do so.
Many macromolecules are synthetic polymers (plastics, synthetic fibers, and synthetic rubber). Polyethylene is produced on a particularly large scale such that ethylenes are the primary product in the chemical industry. Examples or different types of synthetic macromolecules include:
MnO−4 + 8 H+ + 5 e− ⇌ Mn2+ + 4 H2O to be taken into account. The equilibrium constant for a full redox reaction can be obtained from the standard redox potentials of the constituent half-reactions. At equilibrium the potential for the two half-reactions must be equal to each other and, of course, the number of electrons exchanged must be the same in the two half reactions. Redox equilibrium play an important role in the electron transport chain. The various cytochromes in the chain have different standard redox potentials, each one adapted for a specific redox reaction. This allows, for example, atmospheric oxygen to be reduced in photosynthesis. A distinct family of cytochromes, the cytochrome P450 oxidases, are involved in steroidogenesis and detoxification.
==== Autoimmune diseases ==== Low plasma vitamin D concentrations have been reported for autoimmune thyroid diseases, lupus, myasthenia gravis, rheumatoid arthritis, and multiple sclerosis. For multiple sclerosis and rheumatoid arthritis, intervention trials using vitamin D supplementation did not demonstrate therapeutic effects.
Sources: en.wikipedia.org
=== Anti-angiogenic drugs === Osteonecrosis of the jaw has been identified as one of the possible complications of taking anti-angiogenic drugs; the association of the disease with the medication is known as MRONJ. This has been stated in the Drug Safety Updates by the MHRA. Angiogenesis inhibitors interfere with blood vessel formation by interfering with the angiogenesis signalling cascade. They are used primarily to treat cancer. These cancer-fighting agents tend to hinder the growth of blood vessels that supply the tumour, rather than killing tumour cells directly. They prevent the tumour from growing. For example, bevacizumab/aflibercept is a monoclonal antibody that specifically binds to vascular endothelial growth factor (VEGF), preventing VEGF from binding to receptors on the surface of normal endothelial cells. Sunitinib is a different example of an anti-angiogenic drug; it inhibits cellular signalling by targeting multiple receptor tyrosine kinases. It reduces the blood supply to the tumour by inhibiting new blood vessel formation in the tumor. The tumour may stop growing or even shrink.
It may replace glucose in many chemical reactions due to its similarity in structure, may prevent the non-enzymatic glycosylation of proteins, and might reduce glycated hemoglobin (HbA1c) levels. Secondly, vitamin C has also been suggested to play a role in lipid regulation as a controlling catabolism of cholesterol to bile acid.
Sanlúcar de Barrameda (Spanish pronunciation: [sanˈlukaɾ ðe βaraˈmeða]), or simply Sanlúcar, is a city in the northwest of Cádiz province, part of the autonomous community of Andalucía in southern Spain. Sanlúcar is located on the left bank at the mouth of the Guadalquivir River opposite the Doñana National Park, 52 km from the provincial capital Cádiz and 119 km from Sevilla, capital of the autonomous region Andalucía. Its population is 68,656 inhabitants (National Institute of Statistics 2019). Sanlúcar has been inhabited since ancient times, and is assumed to have belonged to the realm of the Tartessian civilization. The town of San Lucar was granted to the Spanish nobleman Alonso Pérez de Guzmán in 1297. Its strategic location made the city a starting point for the exploration, colonization and evangelization of America between the 15th and 17th centuries. Sanlúcar lost much of its strategic value after 1645 because of the disgrace of the House of Medina Sidonia, the general decline of Spain under Charles II, the relocation of the Casa de Contratación to the town of Cadiz in 1717, and the Lisbon earthquake of 1755. In the 19th century the economy of the city was converted to viticulture and summer tourism. The 20th century brought destruction and political upheaval as it did elsewhere in Spain during the Spanish Civil War. Sanlúcar was declared a Cultural Historical-artistic site in 1973. Since the restoration of democracy (1975–1982) its town council has borrowed heavily, making Sanlúcar the city with the lowest per capita income in Spain.
== Biography == Youvan received an associate degree in electronics and a bachelor's degree in biology from Pittsburg State University. He received his Ph.D. degree in biophysics from UC Berkeley in 1981. Youvan was an associate professor of chemistry at MIT, where he specialized in the study of photosynthesis, specifically the spectral analysis of photosynthetic bacteria. Youvan, along with Mary M. Yang, developed instrumentation to study the spectra of bacteria directly from a petri dish.
=== Recruitment and spending policy === Youth development and scouring for talent abroad is central to Wenger's recruitment policy. He relies on a network of scouts and personal contacts to find and attract talented footballers to play under him. Wenger's strategy is aided by data; for instance, the decision to sign Flamini in 2004 came about as he was looking at statistics to find an understudy to Vieira. To examine the mental state of a young footballer, he uses psychometric tests conducted by psychologist Jacques Crevoisier once every two years. Wenger prides himself on nurturing talent, saying in an interview: "I believe one of the best things about managing people is that we can influence lives in a positive way. That's basically what a manager is about. When I can do that, I am very happy". In his early managerial years, Wenger recognised the potential of football in Africa, which influenced his transfer dealings at Monaco. On the recommendation of Claude Le Roy, he signed Liberian George Weah, who later became the first African to be named FIFA World Player of the Year. Weah, while receiving his award from FIFA president João Havelange and vice-president Lennart Johansson invited Wenger up to the stage, spontaneously giving his medal to the manager, as a token of his appreciation. During his final years at Monaco, Wenger worked with Roger Mendy, a Senegalese defender regarded in 1991 as one of the ten best African footballers by France Football, and Nigerian Victor Ikpeba, a forward who earnt the accolade of African Player of the Year.
Sources: en.wikipedia.org
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.
Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.
It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.